These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36592248)

  • 21. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms involved in the development of chronic hepatitis C as potential targets of antiviral therapy.
    Jackowiak P; Figlerowicz M; Kurzyńska-Kokorniak A; Figlerowicz M
    Curr Pharm Biotechnol; 2011 Nov; 12(11):1774-80. PubMed ID: 21902631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and Development of Antiviral Therapies for Chronic Hepatitis C Virus Infection.
    Martinez MA; Franco S
    Adv Exp Med Biol; 2021; 1322():139-157. PubMed ID: 34258740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombination in hepatitis C virus.
    González-Candelas F; López-Labrador FX; Bracho MA
    Viruses; 2011 Oct; 3(10):2006-24. PubMed ID: 22069526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.
    Preciado MV; Valva P; Escobar-Gutierrez A; Rahal P; Ruiz-Tovar K; Yamasaki L; Vazquez-Chacon C; Martinez-Guarneros A; Carpio-Pedroza JC; Fonseca-Coronado S; Cruz-Rivera M
    World J Gastroenterol; 2014 Nov; 20(43):15992-6013. PubMed ID: 25473152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus genetic variability: pathogenic and clinical implications.
    Pawlotsky JM
    Clin Liver Dis; 2003 Feb; 7(1):45-66. PubMed ID: 12691458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus drug resistance and immune-driven adaptations: relevance to new antiviral therapy.
    Gaudieri S; Rauch A; Pfafferott K; Barnes E; Cheng W; McCaughan G; Shackel N; Jeffrey GP; Mollison L; Baker R; Furrer H; Günthard HF; Freitas E; Humphreys I; Klenerman P; Mallal S; James I; Roberts S; Nolan D; Lucas M
    Hepatology; 2009 Apr; 49(4):1069-82. PubMed ID: 19263475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes.
    Bukh J; Miller RH; Purcell RH
    Semin Liver Dis; 1995 Feb; 15(1):41-63. PubMed ID: 7597443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia.
    Lopez-Osorio MC; Usme-Ciro JA; Martínez JW; Peláez-Carvajal D; Hernández J; Hoyos S; Restrepo JC; Navas MC
    Virus Res; 2022 Sep; 318():198847. PubMed ID: 35697300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmaceutical Approaches for Treatment of Hepatitis C virus.
    Milani A; Basimi P; Agi E; Bolhassani A
    Curr Pharm Des; 2020; 26(34):4304-4314. PubMed ID: 32386486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.
    Walker A; Skibbe K; Steinmann E; Pfaender S; Kuntzen T; Megger DA; Groten S; Sitek B; Lauer GM; Kim AY; Pietschmann T; Allen TM; Timm J
    J Virol; 2016 Jan; 90(1):33-42. PubMed ID: 26446603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical impact of hepatitis B and C virus envelope glycoproteins.
    Jeulin H; Velay A; Murray J; Schvoerer E
    World J Gastroenterol; 2013 Feb; 19(5):654-64. PubMed ID: 23429668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inter and intrapatient evolution of hepatitis C virus.
    Di Lello FA; Culasso AC; Campos RH
    Ann Hepatol; 2015; 14(4):442-9. PubMed ID: 26019029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation.
    Kato N
    Microb Comp Genomics; 2000; 5(3):129-51. PubMed ID: 11252351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus. The importance of viral heterogeneity.
    Farci P
    Clin Liver Dis; 2001 Nov; 5(4):895-916. PubMed ID: 11685800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus--T-cell responses and viral escape mutations.
    Petrovic D; Dempsey E; Doherty DG; Kelleher D; Long A
    Eur J Immunol; 2012 Jan; 42(1):17-26. PubMed ID: 22125159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection.
    Pham TN; King D; Macparland SA; McGrath JS; Reddy SB; Bursey FR; Michalak TI
    Gastroenterology; 2008 Mar; 134(3):812-22. PubMed ID: 18243182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.